Denying the fact that technology has drastically impacted the lifestyles of humans is unreasonable, rather we all are aware of the evident benefits of technology in the current era. We have witnessed the advantages of technology in our lives and have dealt with the cons successfully. And, now it’s the time to take a step ahead, incorporating technology into Lifesciences and pharma businesses in India.
“Replacing manual efforts with full-fledged automation has benefitted many businesses, lowering their capital investments and boosting revenues.” That’s nothing but automation!
This automation is being achieved through technological implementations. Now, India being the largest supplier of generic drugs in the globe, is ready to inculcate technology as digitalization in pharma sectors. Integrating all the operational channels internally will automate the whole pharma business to attain the next level of technological innovation with digitalization.
Hurdles faced before actuating digitalization in pharma:
With technology in the picture, pharma in India is reaching a higher level of automation with a lot of positive changes but with several unavoidable hurdles. When all the operations in Lifesciences and healthcare industries were being managed using traditional approaches from ages, the digital transformation is going to get tougher for all pharma businesses. But Indian pharmaceuticals have already decided to move forward with new risks, new failures, new successes, and a lot of new learning.
Putting lights on the challenges being faced by pharma businesses to actuate digitalization will help understand the significance of technological transformation to bolster a business.
Low Code Platforms: A one-stop-shop to all your doubts:
Several pharma companies have already adopted Low Code Platforms to showcase their businesses, but Indian pharma also deserves such amazing options to run digitalization successfully.
Low Code Platforms are developing customized apps keeping all the specific business needs in an account, handling end-to-end business tasks. But before that, let’s discuss the key benefits of a Low Code Platform.
[box type=”success” align=”” class=”” width=””]When Low Code Platforms are handling a large portion of business in digitalized India during the current pandemic, a recent forecast by Gartner says in 2021 there has been a 22.6% increase in the Low Code technology implementation worldwide from 2020. This is an evident sign that Low Code is going to be a vital part of new-age automation, not only in India but around the globe.[/box]
AmpleLogic holds your back:
Talking about this digital transformation journey, pharma businesses in India are coming across a lot of challenges and implementing various strategic ideas to boost digitalization. Agreeing with the abiding regulation of FDA, 21 CFR Part 11 that says all the manual operations have to be done on digital platforms, AmpleLogic is offering several clients with Low Code Platforms with additive quality management services from the last 10 years. Now, the team is working hard to help pharma businesses understand the efficacy of digitalization and various methods to achieve that technological evolution.
Internet shutdown has become global phenomenon. In the first quarter of 2024, Internet disruptions kicked…
India's diversity has long been celebrated as a hallmark and a driver of innovation and…
ET Edge recently had a conversation with Amit Adarkar, CEO of Ipsos India, about the…
Lenovo Group announced a comprehensive new suite of purpose-built AI-centric infrastructure systems and solutions to…
As the scientific community celebrates the remarkable achievements of Covid-19 vaccines, a recent development involving…
The Fundraise of USD 250 Mn, has taken the company’s total Assets Under Management to…